Swiss drugmaker Novartis said on Monday it has opened a new 10,000-square-foot factory in Carlsbad, California, to make ...

The facility is part of the company’s commitment, earlier this year, to invest $23 billion in the U.S. over the next five ...

Carlsbad location is company’s third US-based radioligand therapy (RLT) manufacturing site New site expands manufacturing footprint to meet ...

Swiss drugmaker Novartis opens new manufacturing facility, part of operations expansion in the U.S. that will also invest ...

The Swiss pharmaceutical giant's plant will produce compounds needed for radioligand therapy (RLT), a form of precision ...

"Novartis opens California site for RLT manufacturing" was originally created and published by Pharmaceutical Technology, a ...

Novartis has unveiled a 10,000-square-foot radioligand therapy (RLT) production plant in Carlsbad, CA, representing a move ...

Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...

Swiss pharma giant Novartis announced the opening of a new 10,000-square-foot radioligand therapy (RLT) manufacturing ...

Swiss drugmaker Novartis has launched a new facility in Carlsbad, California, dedicated to producing cancer treatments. The 10,000-square-foot factory will manufacture radioligand therapies for ...

Basel: Novartis, a global medicines company, has announced the opening of a new 10,000-square-foot radioligand therapy (RLT) ...